--- title: "12:00 ETALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation" type: "News" locale: "en" url: "https://longbridge.com/en/news/293643448.md" description: "Hagens Berman (HBSS) is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following whistleblower allegations of financial manipulation. Former executive Hakan Kardes claims the company misclassified expenses to inflate EBITDA and stock price. The news caused ALHC's stock to drop 16.7%. HBSS urges investors with losses to contact them." datetime: "2026-07-23T16:00:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293643448.md) - [en](https://longbridge.com/en/news/293643448.md) - [zh-HK](https://longbridge.com/zh-HK/news/293643448.md) --- # 12:00 ETALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation , /PRNewswire/ -- National shareholder rights firm Hagens Berman (HBSS) is investigating potential violations of U.S. securities laws by Alignment Healthcare, Inc. **(NASDAQ: ALHC)** following reports of a whistleblower lawsuit alleging systemic financial manipulation. **SUBMIT YOUR ALHC INVESTMENT LOSSES TO HBSS** **Visit:** www.hbsslaw.com/investor-fraud/alhc **Contact the Firm Now:** \[email protected\] 844-916-0895 **Alignment Healthcare, Inc. (ALHC) Investigation:** On July 8, 2026, news broke that a former Alignment Healthcare executive had filed a lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results. The whistleblower, Hakan Kardes, who was employed by Alignment from 2019 to 2025 and most recently served as the company's chief transformation officer, alleges that Alignment misclassified operating expenses as capital expenditures. These actions purportedly boosted the company's adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for 2024 and 2025, thereby artificially inflating key performance metrics tied to both the company's stock price and executive compensation. This revelation comes shortly after Alignment Healthcare had aggressively touted strong first-quarter 2026 financial results—including significant revenue growth, a swing to profitability, and raised full-year guidance—which had driven the company's share price toward 52-week highs. Following the disclosure of the whistleblower's claims, Alignment Healthcare's stock experienced a sharp decline, falling approximately 16.7% in a single day, marking the company's worst single-day performance since February 2024. "We're investigating whether Alignment Healthcare misled investors by disseminating false and misleading information regarding its financial health and internal controls. We encourage investors who purchased ALHC securities and suffered significant losses to contact our firm to discuss their legal rights," said **Reed Kathrein**, the Hagens Berman partner leading the firm's investigation. If you invested in Alignment and have substantial losses, or have knowledge that will assist the firm's investigation, **submit your losses now** » If you'd like more information and answers to other frequently asked questions about the firm's Alignment investigation, **read more** » **Whistleblowers:** Persons with non-public information regarding Alignment should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at **844-916-0895** or email **\[email protected\]**. **About Hagens Berman** Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. Attorney Advertising. Prior results do not guarantee a similar outcome in any future case. SOURCE Hagens Berman Sobol Shapiro LLP ### Related Stocks - [ALHC.US](https://longbridge.com/en/quote/ALHC.US.md) ## Related News & Research - [Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation](https://longbridge.com/en/news/294115528.md) - [ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law Firm](https://longbridge.com/en/news/293851575.md) - [21:43 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC](https://longbridge.com/en/news/293688125.md) - [Alignment Healthcare (ALHC) Stock Looks Below Fair Value After Legal Questions](https://longbridge.com/en/news/293823088.md) - [Alignment Healthcare (ALHC) Reports Earnings Tomorrow: What To Expect](https://longbridge.com/en/news/294145313.md)